SV

Sivakumar Venkata Naga Satya Battina

Director Director DIN 02282017
DIN 02282017 First appointment Jan 2005 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Jan 2005
Shareholding value •••• Premium profile

About Sivakumar Venkata Naga Satya Battina

Data last updated:

Sivakumar Venkata Naga Satya Battina was a Director at Fugen Laboratories Private Limited (2005–2008) and Director at Cistra Pharma Laboratories Private Limited (2005–2008). The companies operate in Pharma.

DIN 02282017
Primary Designation Director
Industry Pharma
First Appointment 28 Jan 2005

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Fugen Laboratories Private Limited U24231TG2005PTC045207
Director28 Jan 20052005₹91.8 Lakh (FY 2021)Active
Director10 Feb 20052005Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Fugen Laboratories Private Limited
Cistra Pharma Laboratories Private Limited
Premium access

Shareholding and investment profile for Sivakumar Venkata Naga Satya Battina

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sivakumar Venkata Naga Satya Battina

Sivakumar Venkata Naga Satya Battina was first appointed on 28 Jan 2005 as Director at Fugen Laboratories Private Limited.

Sivakumar Venkata Naga Satya Battina held 2 earlier board appointments: Fugen Laboratories Private Limited (Director, 28 Jan 2005 to 12 Sep 2008); Cistra Pharma Laboratories Private Limited (Director, 10 Feb 2005 to 13 Oct 2008).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available